These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38045161)

  • 1. Indifferent to CSR performance? Market liberalization brings about changes.
    Zhou H; Xu L
    Heliyon; 2023 Nov; 9(11):e22172. PubMed ID: 38045161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stock Market Liberalization and Corporate Green Innovation: Evidence from China.
    Zhang Y; Zhang J; Cheng Z
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33806099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corporate Social Responsibility Disclosure: Responding to Investors' Criticism on Social Media.
    Zhang Y; Yang F
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will R&D make investors more tolerant? Analysis based on the performance forecast of Chinese listed companies.
    Chen Y; Wang Y; Zhao H; Xu W
    PLoS One; 2023; 18(1):e0280237. PubMed ID: 36701361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smog, media attention, and corporate social responsibility-empirical evidence from Chinese polluting listed companies.
    Xiong G; Luo Y
    Environ Sci Pollut Res Int; 2021 Sep; 28(34):46116-46129. PubMed ID: 33410010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corporate social responsibilities, sustainable investment, and the future of green bond market: evidence from renewable energy projects in Morocco.
    Ahmad S; Mokhchy J
    Environ Sci Pollut Res Int; 2023 Feb; 30(6):15186-15197. PubMed ID: 36166123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualified foreign institutional investors and corporate innovation: From the perspective of corporate governance.
    Wang X; Wang W; Shi XY
    Front Psychol; 2022; 13():1005409. PubMed ID: 36467163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Social Wellbeing, Board-Gender Diversity, and Financial Performance: Evidence From Chinese Fintech Companies.
    Ghafoor S; Duffour KA; Khan UF; Khan MK
    Front Psychol; 2022; 13():862897. PubMed ID: 35592173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does CSR performance improve corporate immunity to the COVID-19 pandemic? Evidence from China's stock market.
    Tian J; Wang X; Wei Y
    Front Public Health; 2022; 10():956521. PubMed ID: 36052006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Returnee Executives, Corporate Social Responsibility, and Stock Price Synchronicity.
    Gao D; Zhao Y; Tian Q
    Front Psychol; 2022; 13():950436. PubMed ID: 35911051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of COVID-19 on the Stock Price of Socially Responsible Enterprises: An Empirical Study in Taiwan Stock Market.
    Lee KJ; Lu SL
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33546396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formalization of a new stock trend prediction methodology based on the sector price book value for the Colombian market.
    Leonardo MP; Carlos Eduardo CM; Ana María TH; José Luis TG; Campo Elias LR
    Heliyon; 2022 Apr; 8(4):e09210. PubMed ID: 35392396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental Regulation, Corporate Social Responsibility (CSR) Disclosure and Enterprise Green Innovation: Evidence from Listed Companies in China.
    Xu X; Jing R; Lu F
    Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balance matters more: Research on the effect of corporate social responsibility equilibrium on stock price crash risk.
    Yu S; Tian M
    PLoS One; 2024; 19(10):e0306879. PubMed ID: 39361583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The philanthropic response of substantive and symbolic corporate social responsibility strategies to COVID-19 crisis: Evidence from China.
    Zhong M; Zhao W; Shahab Y
    Corp Soc Responsib Environ Manag; 2022 Mar; 29(2):339-355. PubMed ID: 35465450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Institutional investors and cost of capital: The moderating effect of ownership structure.
    Huo X; Lin H; Meng Y; Woods P
    PLoS One; 2021; 16(4):e0249963. PubMed ID: 33831116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of socially responsible firms during the COVID-19 crisis and trading behavior by investor type: Evidence from the Korean stock market.
    Lee S; Lee D; Hong C; Park MH
    Financ Res Lett; 2022 Mar; 45():102660. PubMed ID: 35002551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do financial performance and firm's value affect the quality of corporate social responsibility disclosure: Moderating role of chief executive officer's power in China.
    Na C; Tian G; Rauf F; Naveed K
    Front Psychol; 2022; 13():925323. PubMed ID: 36059787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does venture capital Quan Zi affect stock mispricing: Evidence from Chinese listed companies.
    Chen P; Deng L
    PLoS One; 2023; 18(4):e0281255. PubMed ID: 37053247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does institutional quality complement the relationship between ownership structure and corporate social responsibility?
    Ali S; Zhang R; Talha M; Ali Z
    Heliyon; 2024 Jun; 10(11):e31994. PubMed ID: 38882305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.